Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-08-30 4 OE $6.46 $19,380 D/D 3,000 102,067 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-08-12 4 OE $6.46 $19,380 D/D 3,000 130,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2006-03-01 4 AB $12.96 $19,490 D/D 1,500 15,500 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2006-06-01 4 AB $13.05 $19,575 D/D 1,500 25,381 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-05-31 4 AS $28.00 $19,880 D/D (710) 129,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-10-01 4 AS $25.10 $19,904 D/D (793) 6,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2006-04-03 4 AB $13.33 $20,019 D/D 1,500 17,000 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-09-02 4 AS $20.89 $20,890 D/D (1,000) 95,067 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-04-28 4 A $66.88 $21,201 D/D 317 426,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-30 4 A $62.59 $21,217 D/D 339 298,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-04-29 4 A $51.26 $21,223 D/D 414 395,635 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-04-30 4 A $29.69 $21,228 D/D 715 195,235 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-04-28 4 A $70.30 $21,232 D/D 302 238,496 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-04-30 4 A $19.35 $21,242 D/D 1,098 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-04-30 4 AB $10.37 $21,248 D/D 2,049 6,120 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-04-29 4 A $11.64 $21,249 D/D 1,826 91,893 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-30 4 A $68.78 $21,254 D/D 309 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-30 4 A $68.78 $21,254 D/D 309 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-04-30 4 A $23.21 $21,256 D/D 916 120,317 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-04-30 4 A $11.64 $21,260 D/D 1,827 50,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-04-30 4 A $62.41 $21,281 D/D 341 303,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-29 4 A $62.41 $21,281 D/D 341 335,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-16 4 OE $21.51 $21,510 D/D 1,000 326,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-09-27 4 OE $21.51 $21,510 D/D 1,000 327,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-30 4 OE $21.51 $21,510 D/D 1,000 328,530 0 -
  853  Records found
  1   2   3   4   5   6   7   8  9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 8 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us